Cellebrite officer David Gee plans sale of 653 shares
Cellebrite DI Ltd. (CLBT) officer David Gee intends to sell 653 ordinary shares on November 12, 2026, under a mandatory, non-discretionary sell-to-cover arrangement solely to satisfy income tax liabilities incurred upon vesting restricted share unit awards.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Cellebrite DI Ltd. (CLBT) officer David Gee intends to sell 653 ordinary shares on November 12, 2026, under a mandatory, non-discretionary sell-to-cover arrangement solely to satisfy income tax liabilities incurred upon vesting restricted share unit awards. The 653 shares were acquired when restricted share units vested under an issuer S-8 registered plan on November 11, 2026.
Gee also reported earlier sales of 230 shares on August 12, 2026, 2,198 shares on August 21, 2026, and 4,323 shares on August 24, 2026.
Key Figures
Key Terms
sell-to-cover arrangement financial
S-8 Registered Plan regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.